Journal
ADVANCED HEALTHCARE MATERIALS
Volume 10, Issue 1, Pages -Publisher
WILEY
DOI: 10.1002/adhm.202001211
Keywords
peptide conjugates; self-assembly; tumor imaging; tumor therapy
Funding
- National Natural Science Foundation of China [21725505, 81821001]
- Ministry of Science and Technology of China [2016YFA0400904]
Ask authors/readers for more resources
Intracellular self-assembly (ISA) is a powerful strategy for constructing complex nanostructures in cells, and has been widely applied in biomedicine and biomedical engineering. Using peptide conjugates for ISA in tumor imaging and treatment has made significant progress, with potential for other important imaging or therapeutic applications.
Intracellular self-assembly (ISA) is a versatile and powerful strategy for in situ constructing sophisticated and functional supramolecular nanostructures, which has been widely applied in biomedicine and biomedical engineering. Among the common building blocks for ISA, peptides have attracted increasingly attention due to their intrinsic bioactivity, biocompatibility, and biodegradability. Particularly, by conjugating functional motifs (e.g., probes or drugs) to peptides to yield the peptide conjugates, the latter show enhanced stability and efficiency, and probably new functions. In recent years, employing ISA of peptide conjugates for tumor imaging and treatment has achieved great progresses. Therefore, the recent progress of ISA of peptide conjugates is summarized in this progress report. Moreover, several examples of ISA of peptide conjugates for other important imaging or therapeutic applications are also introduced. Finally, a brief perspective on remaining challenges and potential directions for future research in this area is presented.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available